Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
401-04-010 ISMRM Abstract

NMR-Based Metabolomics Analysis of Diabetes-Associated Metabolic Dysregulation in Early-Stage Chronic Kidney Disease

Primary: Body - Kidney
Secondary: Body - Metabolism
401-04-010 · Metabolism · Tuesday, 12 May, 4:00 PM–5:50 PM · Hall 1A
Keywords: Kidney NMR spectroscopy Glucose metabolism Biomarker Diabetic Kidney Disease
Accepted
Upasna Gupta 1, Amrita Sahu, Anupama Kaul2, Jiya Mishra1, Subash C Yadav3, Manas Behera2, Bikash Baishya1, Neeraj Sinha1
1Department of Advanced Spectroscopy and Imaging, Centre of Biomedical Research, Lucknow, India
2Department of Nephrology and Renal Transplantation, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
3Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Presenting Author: Upasna Gupta

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Bose, S., Mehta, N. N., Chen, S.-C., Li, S., & McCullough, P. A. (2011). 41 Poor Glycemic Control but not Dyslipidemia is Associated with Albuminuria in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM): A Kidney Early Evaluation Program (KEEP) Report. American Journal of Kidney Diseases, 57(4), B27. https://doi.org/10.1053/j.ajkd.2011.02.044 [doi]
2. Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements, 12(1), 7–11. https://doi.org/10.1016/j.kisu.2021.11.003 [doi]
3. Jelaković, A., Radunović, D., Josipović, J., Željković Vrkić, T., Gellineo, L., Domislović, M., Prelević, V., Živko, M., Fuček, M., Marinović Glavić, M., Bašić-Jukić, N., Pećin, I., Bubaš, M., Capak, K., & Jelaković, B. (2024). PREVALENCE, Characteristics, and Awareness of Chronic Kidney Disease in Croatia: The EH-UH 2 Study. Journal of Clinical Medicine, 13(22), 6827. https://doi.org/10.3390/jcm13226827 [doi]
4. Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005). Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 67(6), 2089–2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x [doi]
5. Yan, M.-T., Chao, C.-T., & Lin, S.-H. (2021). Chronic Kidney Disease: Strategies to Retard Progression. International Journal of Molecular Sciences, 22(18), 10084. https://doi.org/10.3390/ijms221810084 [doi]
6. Deng, Y., Li, N., Wu, Y., Wang, M., Yang, S., Zheng, Y., Deng, X., Xiang, D., Zhu, Y., Xu, P., Zhai, Z., Zhang, D., Dai, Z., & Gao, J. (2021). Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.672350 [doi]
7. Wishart, D. S. (2019). Metabolomics for Investigating Physiological and Pathophysiological Processes. Physiological Reviews, 99(4), 1819–1875. https://doi.org/10.1152/physrev.00035.2018 [doi]
8. Letertre, M. P. M., Giraudeau, P., & de Tullio, P. (2021). Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives. Frontiers in Molecular Biosciences, 8. https://doi.org/10.3389/fmolb.2021.698337 [doi]
9. Charles, K., Lewis, M. J., Montgomery, E., & Reid, M. (2024). The 2021 Chronic Kidney Disease Epidemiology Collaboration Race-Free Estimated Glomerular Filtration Rate Equations in Kidney Disease: Leading the Way in Ending Disparities. Health Equity, 8(1), 39–45. https://doi.org/10.1089/heq.2023.0038 [doi]
10. Sitasuwan, T., & Lertwattanarak, R. (2020). Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand. BMJ Open, 10(11), e041269. https://doi.org/10.1136/bmjopen-2020-041269 [doi]
11. Worley, B., & Powers, R. (2012). Multivariate Analysis in Metabolomics. Current Metabolomics, 1(1), 92–107. https://doi.org/10.2174/2213235x11301010092 [doi]
12. Triba, M. N., Le Moyec, L., Amathieu, R., Goossens, C., Bouchemal, N., Nahon, P., Rutledge, D. N., & Savarin, P. (2015). PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. Molecular BioSystems, 11(1), 13–19. https://doi.org/10.1039/c4mb00414k [doi]
13. Xia, J., Broadhurst, D. I., Wilson, M., & Wishart, D. S. (2012). Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics, 9(2), 280–299. https://doi.org/10.1007/s11306-012-0482-9 [doi]
14. Gupta, U., Sahu, A., Bhadauria, D. S., Baishya, B., & Sinha, N. (2025). Characterizing metabolic dysregulation in early-stage chronic kidney disease for diagnostic insights. Molecular Omics. https://doi.org/10.1039/d5mo00018a [doi]
15. Rolo, A. P., & Palmeira, C. M. (2006). Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology, 212(2), 167–178. https://doi.org/10.1016/j.taap.2006.01.003 [doi]
16. Yako, H., Niimi, N., Kato, A., Takaku, S., Tatsumi, Y., Nishito, Y., Kato, K., & Sango, K. (2021). Role of pyruvate in maintaining cell viability and energy production under high-glucose conditions. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-98082-w [doi]
17. Martínez-Reyes, I., & Chandel, N. S. (2020). Mitochondrial TCA cycle metabolites control physiology and disease. Nature Communications, 11(1). https://doi.org/10.1038/s41467-019-13668-3 [doi]
18. Menezo, Y., Elder, K., Clement, A., & Clement, P. (2022). Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles. Biomolecules, 12(2), 197. https://doi.org/10.3390/biom12020197 [doi]
19. Pfalzer, A. C., Choi, S.-W., Tammen, S. A., Park, L. K., Bottiglieri, T., Parnell, L. D., & Lamon-Fava, S. (2014). S-adenosylmethionine mediates inhibition of inflammatory response and changes in DNA methylation in human macrophages. Physiological Genomics, 46(17), 617–623. https://doi.org/10.1152/physiolgenomics.00056.2014 [doi]
20. Mosharov, E., Cranford, M. R., & Banerjee, R. (2000). The Quantitatively Important Relationship between Homocysteine Metabolism and Glutathione Synthesis by the Transsulfuration Pathway and Its Regulation by Redox Changes. Biochemistry, 39(42), 13005–13011. https://doi.org/10.1021/bi001088w [doi]
21. Irazabal, M. V., & Torres, V. E. (2020). Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease. Cells, 9(6), 1342. https://doi.org/10.3390/cells9061342 [doi]
22. Chade, A. R. (2017). Small Vessels, Big Role. Hypertension, 69(4), 551–563. https://doi.org/10.1161/hypertensionaha.116.08319 [doi]
23. Stanger, O., & Weger, M. (2003). Interactions of Homocysteine, Nitric Oxide, Folate and Radicals in the Progressively Damaged Endothelium. Clinical Chemistry and Laboratory Medicine, 41(11). https://doi.org/10.1515/cclm.2003.222 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/401-04-010